• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应对用于治疗多发性硬化症的药物的口腔副作用。

Managing the oral side-effects of medications used to treat multiple sclerosis.

作者信息

Cockburn N, Pateman K, Taing M W, Pradhan A, Ford P J

机构信息

The University of Queensland, School of Dentistry, UQ Oral Health Centre, Brisbane, Queensland, Australia.

The University of Queensland, School of Pharmacy, Pharmacy Australia Centre of Excellence, Brisbane, Queensland, Australia.

出版信息

Aust Dent J. 2017 Sep;62(3):331-336. doi: 10.1111/adj.12510. Epub 2017 May 31.

DOI:10.1111/adj.12510
PMID:28276076
Abstract

BACKGROUND

Many medications used to manage multiple sclerosis (MS) affect oral health. This review aimed to identify the oral side-effects of the current drugs recommended in Australia to treat MS and make dental practitioners aware of the range of symptoms.

METHODS

The Australian Therapeutic Guidelines and the Australian Medicines Handbook were searched for medications used to treat MS. For each medication, the generic name, class, route of administration, dosage and drug company reported side-effects were extracted from the online Monthly Index of Medical Specialties (MIMs) database. Meyler's Side-effect of Drugs Encyclopaedia was used to identify any additional oral adverse reactions to medications used to treat MS.

RESULTS

Fourteen drugs were identified for the treatment of MS progression and 13 drugs for the treatment of MS symptoms. For these medications, 18 oral side-effects were documented: xerostomia was the most common, followed by dysgeusia, dysphagia, mouth ulceration and sinusitis. Anticholinergic drugs caused xerostomia while immunosuppressants resulted in more infection-related side-effects.

CONCLUSIONS

Dental practitioners should be aware of the range of symptoms likely to be reported by this population. Clinicians are encouraged to continue providing dental care for their patients who develop MS and refer complex cases to specialists.

摘要

背景

许多用于治疗多发性硬化症(MS)的药物会影响口腔健康。本综述旨在确定澳大利亚目前推荐用于治疗MS的药物的口腔副作用,并让牙科医生了解症状范围。

方法

在澳大利亚治疗指南和澳大利亚药品手册中搜索用于治疗MS的药物。对于每种药物,从在线医学专科月度索引(MIMs)数据库中提取通用名、类别、给药途径、剂量和药品公司报告的副作用。使用《梅耶尔药物副作用百科全书》来确定用于治疗MS的药物的任何其他口腔不良反应。

结果

确定了14种用于治疗MS进展的药物和13种用于治疗MS症状的药物。对于这些药物,记录了18种口腔副作用:口干是最常见的,其次是味觉障碍、吞咽困难、口腔溃疡和鼻窦炎。抗胆碱能药物导致口干,而免疫抑制剂导致更多与感染相关的副作用。

结论

牙科医生应了解该人群可能报告的症状范围。鼓励临床医生继续为患有MS的患者提供牙科护理,并将复杂病例转诊给专科医生。

相似文献

1
Managing the oral side-effects of medications used to treat multiple sclerosis.应对用于治疗多发性硬化症的药物的口腔副作用。
Aust Dent J. 2017 Sep;62(3):331-336. doi: 10.1111/adj.12510. Epub 2017 May 31.
2
Oral health impacts of medications used to treat mental illness.用于治疗精神疾病的药物对口腔健康的影响。
J Affect Disord. 2017 Dec 1;223:184-193. doi: 10.1016/j.jad.2017.07.037. Epub 2017 Jul 23.
3
Oral adverse effects of drugs: Taste disorders.药物的口腔不良反应:味觉障碍。
Oral Dis. 2020 Jan;26(1):213-223. doi: 10.1111/odi.13199. Epub 2019 Nov 11.
4
Managing the side effects of medications.管理药物的副作用。
J Dent Hyg. 2000 Winter;74(1):57-69; quiz 71-2.
5
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 3 treatment practicalities and recommendations. MS Neurology Group of the Australian and New Zealand Association of Neurologists.成人多发性硬化症疾病修正治疗的治疗方法:澳大利亚和新西兰视角:第3部分治疗实用性与建议。澳大利亚和新西兰神经学家协会MS神经学组
J Clin Neurosci. 2014 Nov;21(11):1857-65. doi: 10.1016/j.jocn.2014.01.017. Epub 2014 Jun 30.
6
Oral side-effects of the most frequently prescribed drugs.最常处方药物的口腔副作用。
Spec Care Dentist. 1994 May-Jun;14(3):96-102. doi: 10.1111/j.1754-4505.1994.tb01112.x.
7
Clinical management of the dental patient taking multiple drugs.服用多种药物的牙科患者的临床管理。
J Contemp Dent Pract. 2005 Nov 15;6(4):144-51.
8
[Side effects of drugs on the oral cavity].
Med Clin (Barc). 2015 Feb 2;144(3):126-31. doi: 10.1016/j.medcli.2014.01.025. Epub 2014 Mar 13.
9
A retrospective study of drugs associated with xerostomia from the Australian Database of Adverse Event Notifications.澳大利亚不良事件通报数据库中与口干症相关药物的回顾性研究。
Int J Pharm Pract. 2022 Dec 31;30(6):548-553. doi: 10.1093/ijpp/riac051.
10
New oral drugs for the treatment of multiple sclerosis.用于治疗多发性硬化症的新型口服药物。
Br J Hosp Med (Lond). 2016 Sep 2;77(9):502-3. doi: 10.12968/hmed.2016.77.9.502.

引用本文的文献

1
Barriers to dental service access for individuals with multiple sclerosis: a scoping review.多发性硬化症患者获得牙科服务的障碍:一项范围综述
BMC Oral Health. 2025 Jul 2;25(1):1071. doi: 10.1186/s12903-025-06474-5.
2
Evaluation of salivary nitric oxide levels and anxiety in multiple sclerosis patients, with and without Xerostomia: correlation with clinical variables.评估有无口干症的多发性硬化症患者的唾液一氧化氮水平和焦虑情况:与临床变量的相关性
BMC Oral Health. 2025 Apr 8;25(1):507. doi: 10.1186/s12903-025-05878-7.
3
Do people with multiple sclerosis in Saudi Arabia want to know their prognosis? A cross-sectional nationwide study.
沙特阿拉伯的多发性硬化症患者想了解他们的预后情况吗?一项全国性横断面研究。
Neurosciences (Riyadh). 2025 Apr;30(2):108-116. doi: 10.17712/nsj.2025.2.20240094.
4
Oral State and Salivary Cortisol in Multiple Sclerosis Patients.多发性硬化症患者的口腔状态与唾液皮质醇
Biomedicines. 2024 Oct 8;12(10):2277. doi: 10.3390/biomedicines12102277.
5
Oral health-related quality of life is more strongly correlated with mental health than with oral health in relapsing-remitting multiple sclerosis.口腔健康相关生活质量与心理健康的相关性强于与口腔健康的相关性,在复发缓解型多发性硬化症中更是如此。
J Oral Rehabil. 2023 Jan;50(1):62-68. doi: 10.1111/joor.13387. Epub 2022 Nov 7.
6
Oral Health Status and Multiple Sclerosis: Classic and Non-Classic Manifestations-Case Report.口腔健康状况与多发性硬化症:经典与非经典表现——病例报告
Diseases. 2022 Sep 9;10(3):62. doi: 10.3390/diseases10030062.
7
Cognitive function and oral health in relapsing-remitting multiple sclerosis.复发缓解型多发性硬化症患者的认知功能与口腔健康。
Clin Oral Investig. 2022 Mar;26(3):2899-2907. doi: 10.1007/s00784-021-04272-1. Epub 2021 Nov 13.
8
Interventions for Nursing Home Residents with Dysphagia-A Scoping Review.针对吞咽困难养老院居民的干预措施——一项范围综述
Geriatrics (Basel). 2021 May 21;6(2):55. doi: 10.3390/geriatrics6020055.
9
Accuracy of a questionnaire on xerostomia as a screening tool for hyposalivation.口干症问卷作为唾液分泌减少筛查工具的准确性。
Int Dent J. 2020 Dec;70(6):427-434. doi: 10.1111/idj.12586. Epub 2020 Aug 23.
10
Multiple Sclerosis: Impact on Oral Hygiene, Dysphagia, and Quality of Life.多发性硬化症:对口腔卫生、吞咽困难和生活质量的影响。
Int J Environ Res Public Health. 2020 Jun 4;17(11):3979. doi: 10.3390/ijerph17113979.